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Abstract
Diagnosing and treating lesions of the mouth and gums is challenging for most
clinicians because of the wide variety of disease processes that can present with
similar appearing lesions and the fact that most clinicians receive inadequate train-
ing in mouth diseases. Oral cancer, a common lesion in oral cavity, is not correctly
diagnosing a clinical picture of an early squamous cell carcinoma. The prevalence of
oral cancer continues to rise worldwide, related to the increase in consumption of
tobacco, alcohol and other carcinogenic products. However, there has also been a
significant reduction in mortality due to increasing awareness, early diagnosis and
advances in treatments. This chapter is an attempt to provide a comprehensive
update encompassing the spectrum of etiologic/risk factors, current clinical diag-
nostic tools, management philosophies, and molecular biomarkers and progression
indicators of oral cancer.
Keywords: oral cancer, oral cavity cancer, head and neck cancer,
squamous cell carcinoma, oral lesions
1. Introduction
Oral cancer is one of the most prevalent diseases worldwide, accounting for
30–40% of the head and neck cancer. There are an estimated 200,000 cases of
oral cancer worldwide each year, which cause an estimated 100,000 deaths [1].
Particularly, these are malignant lesions of the oral structure including anterior two
thirds of tongue, lips (upper lip, lower lip and edge), the upper and lower gingiva,
retromolar trigone, buccal mucosa and floor of the mouth. The most common
histopathology of oral cancer is squamous cell carcinoma, contributing to approxi-
mately 90% of cases. Multidisciplinary oncologic treatment, such as surgery, radia-
tion therapy and chemotherapy, plays important roles in treatment for oral cavity
cancer [2].
2. Oral cavity anatomy
The oral cavity is composed of the mucosa of the lips (not outer, dry lips), the
buccal mucosa, the anterior tongue, the floor of the mouth, the hard palate and the
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upper and lower gingiva. The anterior boundary is determined by the portion of the
upper lip connected to the lower lip (wet mucosa). While, the posterior side is
bound by the V-groove of the tongue, the anterior tonsillar pillars (palatoglossus
muscles) and the posterior margin of the hard palate. Inferiorly, the oral cavity is
formed by mylohyoid muscles. Additionally, the lateral border of the oral cavity
spans between the buccomasseteric area (buccal mucosa) and retromolar trigone
(Figure 1).
3. Epidemiology and etiology of pathogenesis
An estimated 200,000 cases of oral cancer every year worldwide resulted in
around 100,000 lethal cases [1]. Oral cavity tumors frequently occur with the local
invasions, destructions of the surrounding tissue and lymph node metastases, but
there is not often have distant metastasis at the time of diagnosis. Smoking and
alcohol assumption are two major risks of the oral squamous cell carcinoma [3].
Likewise, in Asia, especially in India, chewing nut quid is also an important key
factor [4]. Furthermore, oral tobacco use, periodontal disease, radiation and immu-
nodeficiency have been considered as risks linked to oral cancer. By the same token,
sun exposure (ultraviolet radiation) is also a causal factor. Both of tobacco assump-
tion and chewing nut quid are predominant risks of buccal mucosa cancers [3, 4].
Figure 2 illustrates Region-Specific Incidence Age-Standardized Rates by Sex for
Cancers of the Lip and Oral Cavity in 2018 [1].
Interestingly, human papillomavirus (HPV) infection, especially HPV 16, is
associated with the incidence rates of tonsilloma and tongue cancer. Yet, the ratio of





relationship between clinical pathology and prognosis. Therefore, the HPV test has
not been recommended for oral cancer [5].
4. Pathology
A total of 90 to 95% of all malignant lesions in the oral cavity are the squamous
cell carcinoma. Moreover, it can be classified into three main groups: good differ-
entiation (above 75% keratinization), moderate differentiation (25–75% keratiniza-
tion) and poorly differentiated tumors (below 25% keratinization). Besides, less
common types of histopathology could be mentioned such as verrucous carcinoma
(a variant of squamous cell carcinoma), adenocarcinoma, adenoid cystic carcinoma
and mucoepidermoid carcinomas.
On the other hand, the squamous cell carcinoma of the head and neck ordinarily
undergo several developments of precancerous lesions due to exposure to carcino-
genic factors.
• Oral leukoplakia is a precancerous lesion that presents as white patches in the
oral mucosa. Notably, this damage is relatively common at a rate of 4% in the
population [6]. Leukoplakia is divided into two types: homogenous lesions and
heterogeneous lesions, in which cancer is highly induced by heterogeneous
lesions. The diagnosis of leukoplakia usually relies on a biopsy to diagnose
histopathology. Aside from that, biopsy is a standard criterion of the
histopathological diagnosis in the clinical leukoplakia [7]. Surgery was
indicated to any cases with small heterogeneous leukoplakia or lesions with
severe dysplasia. Likewise, conservative treatments are regularly indicated for
widespread leukoplakia or lesions with moderate or mild dysplasia [8]. Not to
mention is oral proliferative verrucous leukoplakia (OPVL), a rare case found
in patients. This is a malignant lesion of heterozygous leukoplakia with
multifocal-type surface characteristics, slow progression and immense rate of
malignant transformation. Some of the treatments such as surgery, laser,
Figure 2.
Bar chart of region-specific incidence age-standardized rates by sex for cancers of the lip and Oral cavity in
2018. Source: GLOBOCAN 2018 [1].
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radiation or bleomycin-contained-chemotherapy facilitate to temporarily
control the damage. Nonetheless, the relapse rate or malignant transformation
is up to 70% of patients and the lethal rate contributes to higher than 30% for
around a decade [9].
• Erythroplakia, a type of relatively uncommon lesions, has a relatively high rate
of malignant transformation (above 80%) [10]. This lesion can be recognized
with a red strip, relatively smooth, no symptoms in the floor of the mouth, the
surface of the tongue and the soft palate in elder patients routinely using
tobacco and alcohol. Thus, a complete removing surgery is a major
recommendation in this case [11].
5. Clinical features and staging
5.1 Clinical presentation
The clinical manifestations of the oral cavity cancer are greatly contingent on the
location of the primary tumor. Particularly, some of the symptoms could be found
such as mouth sores or mouth ulcers, loose teeth, dysphagia, weight loss and bleed-
ing. What’s more, tumors of the mucosal surface, at the initial stage, recurrently
appear as an unhealed ulcer with varying degrees of pain and occasionally bleed.
These lesions regularly appear in the range of prior weeks to months that patients
realized and go to the examination.
Above 66% of patients with tongue cancer have local lymph node metastases,
depending on stage T and invasive depth, whereas the rate of lymph node metasta-
sis is significantly lower than that of the hard palate cancer patients [12]. Similarly,
the location and extent of the primary tumor attribute to the variants of clinical
symptoms:
• Tongue cancer may develop as an ulcerative and/or infective lesion (Figure 3).
Clinical signs are regular pain, with or without swallowing dysfunction.
Markedly, the occurrence of those symptoms indicates that the tumor has
deeper invaded into underlying other muscle layers of the tongue. In another
way, it is seen that the disease is not at the early stage but reveals the history of
leukoplakia or erythema in patients as well.
• Buccal mucosa cancer (Figure 4) can be presented with parotitis resulted from
the pinched tumor-pinched-Stensen’s duct sign.
• Oral cancer can induce one or both sides of the gland inflammation due to
tumor compression and/or blockage of the Wharton duct leading to a palpable
mass in the submandibular area, which may be the symptom.
• Upper gingival cancer at the early stage is easily bewildered with perianal
infections which are inefficiency when being antibiotics-treated. Furthermore,
sores, wounds and tooth loss could happen at the advanced stage.
• Lip cancer is generally presented with an exophytic or an ulcerative
lesion, occasionally associated with bleeding or pain. Some cases indicate





All patients with the oral tumor should have a completely general examination
for both head and neck areas which includes finding and evaluating secondary
tumors in the upper gastrointestinal tract as well as regional lymph nodes.
5.2.1 Intraoral examination
The process of the oral examination requires to systematically observe and touch




Cancer of anterior two thirds of tongue.
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the upper, lower gingiva and the retromolar trigone. It is advisable to use a tongue
depressor with good light (headlight) to fully observe all positions of the oral cavity.
Then again, the size and characteristics of the lesion are evaluated, including the
extent of invasion (endophytic or exophytic) and the relationship of lesion with
surrounding structures.
5.2.2 Extraoral examination
With patients suffering from oral tumors, it is strongly advised that the facial
skin and scalp are strongly advised to carefully observe and palpate. Besides, the
major salivary glands and metastatic lymph nodes of the neck are evaluated. For
instance, the sensation of the forehead, cheeks, upper lip, chin and lower lip should
be assessed to find the clinical evidence of tumor-invaded-nerve.
The lymph nodes of the head and neck should be thoroughly and systematically
such as preauricular, periparotid, submental, prevascular facial, submandibular,
deep jugular and posterior triangle lymph nodes. Having said that, neck lymph
nodes I, II and III are concerned as the most metastatic lymph-node groups of oral
cancer. Whenever abnormal lymph nodes are detected, a conscientious assessment
of the location, size, amount and clinical signs of the invasive lymph nodes is
conducted.
5.3 Tissue diagnosis
In the oral tumor case, the histopathological diagnosis is preferentially carried
out by a “bite” or excisional biopsy with few pieces from the boundary of benign
and malignant lesions. This procedure should be performed in a specialized clinic
with anesthetics. Similarly important is that the biopsy piece must be resected at the
margin of positive and negative lesions. Additionally, the biopsy piece is necessary
to take a sufficient depth to ensure the quality and necrotic area should be averted.
If the anatomy is negative but clinically suspected to be cancerous, a biopsy is
advisory performed until the procedure is positive. Notably, the fine needle aspira-
tion biopsy applied into the metastasis-suspected lymph nodes in the neck also
facilitates to identify and diagnose the disease stage. Nevertheless, this technique
should be conducted under ultrasound guidance to enhance accuracy.
5.4 TNM staging system
The tumor, node, metastases (TNM) staging system of the American Joint
Committee on Cancer (AJCC) and the Union for International Cancer Control
(UICC) is used to classify cancers of the head and neck (Table 1) [13]. The T
classifications indicate the extent of the primary tumor and are site specific; there is
considerable overlap in the cervical N classifications.
5.5 Staging evaluation
Diagnostic imaging tools coupled with clinical examination help to accurately
assess the stage of the disease, especially the extent of tumor invasion, lymph node
metastasis, distant metastasis and the occurrence of second primary cancer. The
most common metastatic areas are the lungs, liver and bone. Meanwhile, the second





The tumor, node, metastases (TNM) staging system of the American Joint Committee on Cancer (AJCC) and
the Union for International Cancer Control (UICC) is used to classify cancers of the head and neck [13].
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5.5.1 Fine needle aspiration (FNA) biopsy
Fine needle aspiration biopsy was used in the case with a patient with metastatic
cervical lymph nodes. This technique has high sensitivity and specificity, markedly,
diagnostic accuracy is in the range of 89–98% [14, 15]. Yet, if a metastatic neck
lymph node was suspected contrary to the negative FNA result, FNA needed to be
re-conducted before an open biopsy being performed.
5.5.2 Diagnostic methods
5.5.2.1 Primary tumor
Both of CTs with intravenous contrast and magnetic resonance imaging can
diagnose the tumor’s invasion to surrounding organs. Indeed, axial and sagittal
MRI scan can accurately assess tumor depth. However, CT scan with contrast allows
an accurate approach to measure how deep bone could be invasive such as tumors
in the hard palate, gums or floor of the mouth [16]. While, magnetic resonance
is superior to CT that could evaluate the degree of soft tissue invasion, nerve
invasion [17].
5.5.2.2 Nodal metastases
CT with intravenous contrast and MRI can facilitate the diagnosis of metastatic
lymph node and extranodal spread circumstances. In other words, the lymph nodes
with an increase in size enhancement, round, rim enhancement and central necrosis
are suspected as malignant ones [18, 19].
5.5.2.3 Distant metastasis
Diagnosis of the presence of distant metastasis is highly important to determine
the treatment and prognosis of the patients. Chest X-rays may be indicated to the
early-staged cases or patients with low-risk lesions and non-smokers. However, in
the advance-staged patients, the risk of lymph nodes N2,3 and bilateral lymph
nodes are under a higher possibility of a distant invasion. Hence, chest CT or PET/
CT are recommended to this group [20]. No differences have been found in the
diagnosis of metastatic lung lesions between chest CT and PET/CT [21].
6. Treatment
The comprehensive management of oral cancer requires a disciplinary specialty
including head and neck surgery, radiotherapy, medical oncology, imaging, pathol-
ogy, microsurgery, nutrition, social workers and nurses. Generally, surgery is the
primary treatment for oral squamous cell carcinoma. Surgery allows an accurate
assessment of the anatomical stage, margins, invasive status and histopathological
characteristics, based on the pros and cons that can determine the strategy. Adju-
vant radiotherapy  chemotherapy is used on locoregionally advanced tumors if
being indicated. Multidisciplinary coordination is also extraordinarily important to
ensure treatment outcomes. To individualize treatment, several factors need to be
carefully considered, in which the risk of treatment-related complications should be
assessed based on age, comorbidities (e.g., cardiovascular condition, respiration… ),





Generally, surgery is the primary treatment for oral cancer. Remarkably, the
general principles of surgical treatment will be discussed in this article such as the
surgical approach to oral cancer, management of the mandible, management of
neck lymph nodes and reconstruction of defects after oral surgery.
6.1.1 Management of primary tumor
The surgical purpose is to completely remove the primary tumor with negative
margins as well as evaluate the stage and treatment of regional lymph nodes [22].
Every attempt should be made to ensure negative resection margins since positive
margins are associated with a worse prognosis. The rate of local control significantly
increased when the resection distance to the tumor was greater than 0.5 cm com-
pared to less than 0.5 cm (36 and 18%, respectively) [23]. Moreover, the surgical
approach is determined by the location and size of the tumor (Figure 5). The
possibility of complete resection with a negative margin in the three dimensions is
the most important factor in determining the approach. Lesions located in the
anterior or lateral oral tongue, superficial tumors of the anterior floor of mouth are
resected transorally. However, in the case, the invasion intensively toward posterior
and/or on patients with trismus and/or obstructive dentition may require a more
invasive approach such as the lip-splitting paramedian mandibulotomy approach
[24]. The upper cheek flap and midfacial degloving approaches are indicated for
gaining access to the maxilla.
6.1.2 Management of the mandible
Management of the mandible is an important consideration in oral cancer sur-
gery since the proximity of the primary tumor to the mandible or invasion of the
mandible by primary tumor requires resection of some part of the mandible. The
mandibular invasion can occur at an early stage of tumors of the floor of the mouth,
lower gingiva. Thus, assessment of the mandible is essential for appropriate surgical
planning and treatment. In some circumstances, the floor of the mouth tumors can
be removed via transoral approach, regularly combined with marginal or segmental
mandibulectomy. The local control rate is declined to own to the mandibular inva-
sion. That said, this resection is based on an assessment of the invasive cortex and
bone marrow before surgery. The current indications for marginal mandibulectomy
are: (1) for obtaining satisfactory three-dimensional margins around the primary
tumor, (2) when the primary tumor approximates the mandible and (3) for mini-
mal erosion of the alveolar process of the mandible (Figure 6).
The current indications for segmental mandibulectomy include: (1) gross inva-
sion by oral cancer; (2) proximity of oral cancer to the mandible in a previously
irradiated patient; (3) invasion of the inferior alveolar nerve or canal by tumor
[12, 25, 26].
6.1.3 Management of neck lymph nodes
Management of the neck is a key component of oral cavity cancer treatment.
Sixty percentage of patients with metastatic cervical lymph nodes (cN0) in the
early stage of oral cancer cannot be clinically detected. Additionally, approximately
20–30% has evidence of microscopic lymph node metastasis on pathology after the
selective neck dissection (SND). The risk of neck lymph node metastasis is associ-
ated with several factors such as tumor size, histologic grade, depth of invasion,
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perineural invasion and vascular invasion [27, 28]. Cervical lymph node metastasis
is the most essentially prognostic aspect of oral cancer. To give an illustration,
comparing to a similar primary tumor without lymph node metastases, the chance
of survival is declined by 50% [29]. Squamous cell carcinoma of the mobile tongue
and the floor of the mouth are likely to metastases of the cervical lymph nodes, so
these patients should have a selective neck removal surgery even with early-stage
tumors, especially, the tumor thickness > 4 mm [30]. The SND is not indicated in
the circumstances of the hard palate and maxillary gland tumors owing to their less
possibility to have lymph node metastasis. Sentinel node biopsy may be an alterna-
tive to SND in patients with early stage (cT1,2 N0) squamous cell carcinoma.
Notably, this technique was initially published in 2001 by Shoaib and colleagues,
then analyzed in several single-center studies and two multi-center clinical trial
Figure 5.
Surgical approaches to oral cavity [12].
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studies, one in the US and one in Europe [31]. On the other hand, the procedure is
still a big technical challenge and unsustainable success in identifying lymph nodes
and metastases which highly dependent on the experience and competence of
surgeons. That is to say, this technique could only be performed in some of the
intensive centers with proficient skills. In some patients with lymph node metasta-
sis on clinical examination or diagnostic imaging, therapeutic comprehensive neck
dissection is indicated, including cervical lymph node group I to V group. The
conservation or destruction of other structures such as the spinal accessory nerve,
sternocleidomastoid muscle, or internal jugular is vein reliant on the location as well
as the metastatic characteristics. The most common type of comprehensive neck
dissection is the modified radical neck dissection, MRND Type 1. Radical neck
dissection is rarely performed unless there is a direct extranodal spread of the
lymph nodes to evade into the corresponding organs. Likewise, in patients without
clinical lymph node metastases, the underlying risk of lymph node metastasis is
mainly in the group I-III, rarely in the groups IV and V. Thus, supraomohyoid neck
resection (SOHND) is commonly sufficient for stage cN0. Similarly, the rate of
neck recurrence is 10–24% was found in patients who have positive lymph nodes
under SND treatment [32]. Then again, patients are appropriately chosen to opti-
mize postoperative radiation therapy. Particularly, the failure control rate is
reported less than 10% in patients with cN0 demonstrated no lymph node metasta-
sis on pathology [33].
6.1.4 Reconstructive surgery
Reconstructive surgery plays an important role in treatment for oral cavity
cancer. The defects after surgery can cause significant issues in airway manage-
ment, mastication, speech and cosmesis. The aim of reconstructive surgery is to
restore presurgical function and cosmesis. Primary reconstruction, rather than a
secondary surgery, has become the first choice of treatment for most cases with oral
cancer. Primary closure or the use of skin graft can indicate for defects after oral
surgery of early stage tumors. Contrarily, with large and complex defects after the
oral tumor resection, plastic surgery needs the participation of an expert recon-
structive surgeon. Microvascular free flap surgery is the prevailingly preferential
Figure 6.
(A) Cancer of lower gingiva. (B) Marginal mandibulectomy for cancer of lower gingiva.
11
Oral Cancer: The State of the Art of Modern-Day Diagnosis and Treatment
DOI: http://dx.doi.org/10.5772/intechopen.91346
technique. For instance, application of the free radial forearm flap into patients with
soft tissue defects of tongue, the floor of mouth or retromolar trigone apparently
performs an excellent result. In addition to the purpose of covering the soft tissue,
the free flap is also a reliable method for recovering the bone defects, such as the
fibula free flap used as post-surgical reconstruction after segmental
mandibulectomy. Other combined microvascular flanges could be considered as
radial forearm osteocutaneous flap, iliac crest and scapula free flaps. What’s more,
a few studies have demonstrated the effectiveness and safety of microsurgery [34].
The potency to recover major defects after surgery has contributed to improving
the oncologic outcomes in patients with locally advanced stage due to increased
ability to complete resection [35]. Pedicled myocutaneous flaps such as the
pectoralis major, latissimus dorsi or trapezius flaps may also be a promising alter-
native when there is no reconstructive surgeon or the patient’s condition is
inappropriate for microvascular surgery.
6.2 Adjuvant treatment
Postoperative adjuvant therapy is indicated to patients with high risks of the
local, regional recurrence, including pT3,4 primary tumors, pN2,3 lymph node
metastases, level IV or V lymph node metastases, positive margins, lymphovascular
invasion, perineural invasion and extracapsular spread. Indeed, external beam
radiation is the traditional adjuvant treatment, with doses of 60–70 Gy often pro-
viding positive control. Two clinical trials have shown that adjuvant radiotherapy
with cisplatin significantly improves the control rates along with survival time
compared to the single adjuvant radiation therapy in those who have invasive head
and neck cancer with extracapsular spread [36, 37]. But for all that concomitant
radiotherapy has more severe side effects, so it should be carried out in the large
centers with an expert team and appropriate infrastructure.
7. Prognosis
The clinical stage is the key predictor of survival. The Surveillance, Epidemiol-
ogy and End Results (SEER) Cancer Statistics reveal that a 5-year survival for locally
advanced oral cavity cancer of 54.7%, in contrast to 82.5% for early-stage cancer
patients treated from 1975 to 2007 [38]. Lymph node metastasis is the single most
important prognostic factor for oncologic outcome in oral cancer [39]. Besides, the
number and size of positive lymph nodes, the presence of extranodal extension
higher histologic grade, the presence of perineural invasion and increasing size have
been correlated with worse outcomes [40–42].
8. Following
Oral cancer has a high risk of local, regional recurrence and development of a
secondary primary cancer, but the recurrent rate due to distant metastases is rela-
tively low. The contingency of the second cancer is about 4–7% annually [43]. A
comprehensive clinical examination and high vigilance are the cornerstones of the
early diagnosis. That’s said, lifestyle modifications, such as smoking and drinking
management should be a priority since these factors increase the risk of treatment
failure and the appearance of second cancer. Unfortunately, preventive chemicals
are ineffective and follow-up is the second crucial step. Basic imaging is usually
indicated every 3–6 months after the end of treatment or clinical signs are
12
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suspected. Chest radiographs are not routinely used but may be useful in some
patients with a history of tobacco addiction. Additional assessments could be
included oral and swallowing rehabilitation if being indicated, thyroid hormone test
if neck-area radiation and periodic dental examinations are performed.
9. Conclusions
The treatment outcome of oral cancer in recent decades has compellingly
improved with the advancement in reconstructive surgery and adjuvant treatment.
Further improvement in prolonging survival is hampered by an increase in the
second-cancer incidence in long-term patients. With this in mind, oral cancer
prevention is the first step, following that a requirement of enhancing awareness,
promoting education, improving lifestyle and developing early diagnosis tools
should have high consideration.
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